Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Officer List Memo, February 8, 2012 - Octaplas


To:                   The File
Date:                February 8, 2012
BLA:               STN 125416/0              
Sponsor:          Octapharma Pharmazeuticka Produktiosges.m.b.
Product:           Pooled Plasma (Human), Solvent/Detergent Treated
From:              Pratibha Rana
Section 916 of the Food and Drug Administration Amendments Act (FDAAA) requires that the identity of each employee or officer who participated in the decision to approve an original application be listed and filed as part of the Action Package for that file.
The following employees and officers have consented to have their names published publicly as being a participant in the approval decision for this file.
Mitchell M Frost
Jie He
Anthony Lorenzo
Iftekhar Mahmood,
Randa Melhem
Mikhail V Ovanesov,
Ze Peng
Pratibha Rana
Renee Rees
Christine Drabick
Michael (Keith) Wyatt

Page Last Updated: 02/15/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English